HTA and SHINE Announce Moly-99 Supply Agreement

June 21st, 2016 | Posted in: Press Release

Beijing, China – HTA Co., Ltd. (HTA), the largest Chinese producer and distributor of radio-pharmaceuticals, and SHINE Medical Technologies (SHINE), a U.S. company dedicated to being the world leader in the safe, clean, affordable production of medical isotopes, announced today that the companies have entered into a strategic agreement for the supply of molybdenum-99 (moly-99). The supply agreement, which marks HTA’s first with a U.S. supplier of moly-99, demonstrates both companies’ ongoing commitment to ensuring that the medical imaging community has reliable and secure access to moly-99 to meet the needs of patients.

Share on FacebookTweet about this on TwitterShare on Google+Share on LinkedInEmail this to someonePrint this page
Read More +